[1] FISHER C J, MARRA M N, PALARDY J E, et al. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study [J]. Crit Care Med, 1994, 22(4): 553-558.
[2]JAGIELLO P, KLEIN W, SCHULTZ H, et al. Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/permeability increasing protein (BPI) gene[J]. Int J Immunogenet, 2005, 32(1): 3-6.
[3]KLEIN W, TROMM A, FOLWACZNY C, et al. A polymorphism of the bactericidal/permeability increasing protein (BPI) gene is associated with Crohn's disease[J]. J Clin Gastroenterol, 2005, 39(4): 282-283.
[4]HUBACEK J A, PITHA J, SKODOVA Z, et al. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction[J]. Clin Chem Lab Med, 2002, 40(11): 1097-1100.
[5]OOI C E, WEISS J, ELSBACH P, et al. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability increasing protein[J]. J Biol Chem, 1987, 262(31): 14891-14894.
[6]CHRISTOPHER K T, THOMAS J S, SHI X W, et al. Genetic markers for improved disease resistance in animals (BPI) [J]. United States, Kind Code: Al, Patent Application, 2004, 23: 49-80.
[7]朱璟, 潘章源, 訾臣, 等. 11个猪种群体BPI基因第10外显子HpaⅡ遗传变异分析[J]. 中国畜牧杂志, 2011, 47(23): 14-17.
[8]杨静, 李成云, 王云月, 等. 酿酒酵母分泌蛋白组的计算机分析[J]. 中国农业科学, 2005, 38(3): 516-522.
[9]DENTENER M A, FRANCOT G J, BUURMAN W A. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes[J]. J Infect Dis, 1996, 173(1): 252-255.
[10]MANNION B A, KALATZIS E S, WEISS J, et al. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification [J]. J Immunol, 1989, 142(8): 2807-2812.
[11]TAKAHASHI M, HORIUCHI Y, TEZUKA T. Presence of Bactericidal/permeability increasing protein in human and rat skin[J]. Exp Dermatol, 2004, 13(1): 55-60.
[12]BEAMER L J, CARROLL S F, EISENBERG D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution[J]. Science, 1997, 276(5320): 1861-1864.
[13]ZOR T, MAYR B M, DYSON H J, et al. Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators[J]. J Biol Chem, 2002, 277: 42241-42248.
[14]CALARESE D A, SCANLAN C N, ZWICK M B, et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition[J]. Science, 2003, 300(5628): 2065-2071.
[15]朱立平. 蛋白质糖基化与B细胞免疫[J]. 上海免疫学杂志, 2001, 21(4): 193-194.
[16]HUBACEK J A, BUCHLER C, ASLANIDIS C, et al. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved[J]. Biochem Bioph Res Co, 1997, 236(2): 427-430.
[17]IOVINE N M, ELSBACH P, WEISS J. An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains[J]. Proc Natl Acad Sci USA, 1997, 94(20): 10973-10978.
[18]叶兰, 訾臣, 刘璐, 等. 仔猪BPI基因表达水平与大肠杆菌F18菌株感染的关系[J]. 遗传, 2011, 33(11): 1225-1230. |